A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of Plasminogen Activator Inhibitor Type-1
D'Amico, Salvino; Martial, Joseph; Struman, Ingrid
Plasminogen activator inhibitor-1; Reactive Centre Loop; peptide
Abstract :
[en] Plasminogen Activator Inhibitor-1 (PAI-1) is the primary inhibitor of plasminogen activators (uPA and tPA) and thus plays a central role in fibrinolysis. The spontaneous insertion of its Reactive Centre Loop (RCL) into beta-sheet A is responsible for its irreversible conversion into the inactive latent form. In this study, we used two peptides mimicking residues P14-P9 and P8-P3 of the RCL so as to understand this dynamic process. We show that both peptides inhibit the formation of PAI 1/uPA and PAI-1/tPA complexes via two different mechanisms. Targeting the N-terminal part of the loop induces the cleavage of PAI-1 by the proteases uPA/tPA while targeting its C-terminal part greatly favors the irreversible formation of latent PAI-1.
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > Département des sciences de la vie
Struman, Ingrid ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Language :
English
Title :
A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of Plasminogen Activator Inhibitor Type-1
Silverman, G.A. et al. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
Irving, J.A., Pike, R.N., Lesk, A.M. and Whisstock, J.C. (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 10, 1845-1864. (Pubitemid 32049132)
Huntington, J.A. (2006) Shape-shifting serpins-advantages of a mobile mechanism. Trends Biochem. Sci. 31, 427-435.
Law, R.H. et al. (2006) An overview of the serpin superfamily. Genome Biol. 7, 216.
Aertgeerts, K., De Bondt, H.L., De Ranter, C.J. and Declerck, P.J. (1995) Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nat. Struct. Biol. 2, 891-897.
Dupont, D.M., Madsen, J.B., Kristensen, T., Bodker, J.S., Blouse, G.E., Wind, T. and Andreasen, P.A. (2009) Biochemical properties of plasminogen activator inhibitor-1. Front. Biosci. 14, 1337-1361.
Gils, A. and Declerck, P.J. (2004) The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb. Haemost. 91, 425-437. (Pubitemid 38396864)
Andreasen, P.A. (2007) PAI-1 - a potential therapeutic target in cancer. Curr. Drug Targets 8, 1030-1041.
Stout, T.J., Graham, H., Buckley, D.I. and Matthews, D.J. (2000) Structures of active and latent PAI-1: a possible stabilizing role for chloride ions. Biochemistry 39, 8460-8469. (Pubitemid 30489942)
Dupont, D.M. et al. (2006) Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C. J. Biol. Chem. 281, 36071-36081. (Pubitemid 46041340)
Gorlatova, N.V., Elokdah, H., Fan, K., Crandall, D.L. and Lawrence, D.A. (2003) Mapping of a conformational epitope on plasminogen activator inhibitor-1 by random mutagenesis. Implications for serpin function. J. Biol. Chem. 278, 16329-16335. (Pubitemid 36805595)
Verhamme, I., Kvassman, J.O., Day, D., Debrock, S., Vleugels, N., Declerck, P.J. and Shore, J.D. (1999) Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding. J. Biol. Chem. 274, 17511-17517.
Naessens, D., Gils, A., Compernolle, G. and Declerck, P.J. (2003) Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition. Thromb. Haemost. 90, 52-58. (Pubitemid 36873858)
Li, S.H., Gorlatova, N.V., Lawrence, D.A. and Schwartz, B.S. (2008) Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands. J. Biol. Chem. 283, 18147-18157.
Kvassman, J.O., Lawrence, D.A. and Shore, J.D. (1995) The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A. J. Biol. Chem. 270, 27942-27947.
Xue, Y., Bjorquist, P., Inghardt, T., Linschoten, M., Musil, D., Sjolin, L. and Deinum, J. (1998) Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Structure 6, 627-636. (Pubitemid 28258115)
Lawrence, D.A., Olson, S.T., Palaniappan, S. and Ginsburg, D. (1994) Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem. 269, 27657-27662. (Pubitemid 24346602)
Jensen, J.K., Thompson, L.C., Bucci, J.C., Nissen, P., Gettins, P.G., Peterson, C.B., Andreasen, P.A. and Morth, J.P. (2011) Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability. J. Biol. Chem. 286, 29709-29717.
Eitzman, D.T., Fay, W.P., Lawrence, D.A., Francis-Chmura, A.M., Shore, J.D., Olson, S.T. and Ginsburg, D. (1995) Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J. Clin. Invest. 95, 2416-2420.
Gooptu, B. and Lomas, D.A. (2009) Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu. Rev. Biochem. 78, 147-176.
Yamasaki, M., Li, W., Johnson, D.J. and Huntington, J.A. (2008) Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255-1258.
Yamasaki, M., Sendall, T.J., Harris, L.E., Lewis, G.M. and Huntington, J.A. (2010) Loop-sheet mechanism of serpin polymerization tested by reactive center loop mutations. J. Biol. Chem. 285, 30752-30758.
Mahadeva, R., Dafforn, T.R., Carrell, R.W. and Lomas, D.A. (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin- related cirrhosis. J. Biol. Chem. 277, 6771-6774. (Pubitemid 34953057)
Zhou, A., Stein, P.E., Huntington, J.A., Sivasothy, P., Lomas, D.A. and Carrell, R.W. (2004) How small peptides block and reverse serpin polymerisation. J. Mol. Biol. 342, 931-941. (Pubitemid 39172170)